Increasing evidence supports the role of atrial natriuretic factor (ANF) in the modulation of gastrointestinal physiology. The effect of ANF on exocrine pancreatic secretion and the possible receptors and pathways involved were studied in vivo.
Introduction
Atrial natriuretic factor (ANF) is synthesized and released by mammalian atrial cardiocytes in response to mechanical (atrial stretch) or neuroendocrine stimuli (α-adrenergic stimulation or endothelin-1) (15, 42) . ANF is a member of the natriuretic peptide family and plays an important role in the maintenance of cardiovascular and renal functions (9, 15) . Although the heart is the main source of ANF, extra-cardiac sites of production have also been described. Local synthesis of ANF has been reported in the central nervous system, adrenal glands, and salivary glands as well as along the gastrointestinal tract, where this peptide appears to play a paracrine role (17, 23, 26) . Receptors for the natriuretic peptides, both coupled and uncoupled to guanylyl cyclase (GC), are widely distributed supporting a wide spectrum of biological actions for these peptides (2, 9) . Three different natriuretic peptide receptors have been described. NPR-A and NPR-B are coupled to GC whereas NPR-C, also called clearance receptor, is coupled to PLC and/or the inhibition of adenylyl cyclase (AC) (2) . Natriuretic peptides receptors are present in the central nervous system, liver, pancreas and salivary glands as well as along the gastrointestinal tract (20, 40, 36, 11, 23, 38) .
The fact that ANF and its receptors are expressed in the gastrointestinal tract suggests that ANF is likely to have a role acting as an autocrine and/or paracrine regulatory peptide. The participation of ANF in the regulation of gastrointestinal physiology is strongly supported by the finding that ANF gene expression changes along with the digestive state (18) . Different biological effects evoked by ANF have been reported in the gastrointestinal tract as well as in exocrine glands (4) (5) (6) 12, 16, 33) . We have previously shown that peripherally as well as centrally applied ANF modifies spontaneous and bile salt-evoked bile secretion in the rat (16, 7) . ANF diminishes bile acid dependent flow and 4 alkalinizes bile. The effect of ANF on bile secretion is independent of the autonomic nervous system activity. Further, we also reported that ANF is not a sialogogic agonist but it potentiates agonist-induced salivary secretion in both parotid and submaxillary glands (5) . ANF stimulates α-adrenergic, cholinergic and peptidergic (substance P) evoked salivation and modifies electrolyte composition and protein output in agonist-induced secretion (4, 5) . The intracellular signaling pathway of ANF in salivary glands involves the activation of PLC that triggers the intracellular signaling cascade that mediates the stimulus-secretion coupling mechanism in the gland (6) . Other gastrointestinal effects reported for ANF include stimulation of intestinal motility and modulation of intestinal absorption as well as of gastric acid secretion (12, 33) .
Exocrine pancreatic secretion is controlled by humoral and neural interactions that involve the participation of several regulatory peptides and neurotransmitters. The role of different regulatory peptides such as secretin, CCK, neurotensin, PYY, motilin and pancreatic islet hormones have been well established while others still remain to be investigated (13) . Growing evidence supports the role of ANF in the central as well as peripheral regulation of digestive secretions. ANF has a potential role in the regulation of exocrine pancreatic secretion supported by the finding of its mRNA in the gut and the presence of natriuretic peptide receptors in the pancreas (17, 11) . Further, immunohystochemical studies revealed the presence of ir-ANF in acinar and centroacinar cells as well as in cells of the intercalated duct in the pancreas and nerve fibers (1) . ANFevoked cGMP formation has also been reported in the pancreas (11) .
In the present work we sought to establish the effect of ANF on spontaneous as well as evoked exocrine pancreatic secretion in the rat and to characterize the receptors and pathways involved. Our findings showed that ANF stimulated spontaneous as well as 5 hormone-evoked pancreatic secretion in the rat through the phosphoinositide (PI) pathway mediated by NPR-C receptor activation. The autonomic nervous system, hemodynamic changes, CCK, secretin or nitric oxide (NO) release were not involved in ANF secretory response. 6 
Materials and Methods
Sprague-Dawley strain rats (Facultad de Farmacia y Bioquímica, University of Buenos Aires, Argentina) between 250 and 300 g were used in the experiments. The animals were housed in steel cages and maintained at a temperature between 20 and 23°C in a controlled room with a 12-h light-dark cycle. All rats were given water and Purina commercial chow ad libitum. The food, but not the water, was withheld for at least 18 h before the experiments to avoid the release of different hormones or peptides that may alter pancreatic flow. All drugs were purchased from Sigma Chem. Co, St Louis, MI, USA, unless indicated. Other reagents were of analytical purity and obtained from standard sources. All experiments were performed following the National Institute of Health guidelines for the care and use of laboratory animals.
Pancreatic secretion experiments:
Rats were anesthetized with urethane (1.25 g/kg, i.p) and the left jugular vein was cannulated for the infusion of saline (control group), ANF (rat 99-126 Peninsula Lab, Inc., CA, USA), secretin or CCK-8. The common bile duct was exposed and cannulated near the liver. The distal end of the cannula (PC-10 Intramedic, USA) was placed into the duodenum to allow free circulation of bile. A second cannula (PC-10 Intramedic, USA) was placed at the distal end of the bile duct near the duodenum to collect pure pancreatic juice samples. Pylorus ligation was performed to prevent acid from entering the duodenum and affecting pancreatic secretion. The secretion was allowed to flow for 15 min in order to stabilize the flow and to remove bile present in the duct.
Pancreatic secretion samples were then collected for 20 minutes (basal period) and for 30 min during the infusion of saline (control group), ANF (0.5, 1 and 2 µg/kg/h), secretin (0.1, 0.5, 1 and 2 U/kg/h) or CCK (10, 50 and 100pmol/kg/h). Exocrine pancreatic flow was calculated as µl/min/100g body weight. Sodium, potassium and chloride concentration was determined in each sample by the ion electrode method (Technolab, Argentina) and results 7 expressed as mEq/min/100 g body weight. Proteins were measured according to Lowry et al., (30) and expressed as µg/ min/100 g body weight.
ANF/secretin and ANF/CCK interaction: The interaction between ANF and the major hormones that control the exocrine pancreatic secretion was studied by the co-infusion of ANF (0.5µg/kg/h) and secretin (0.05 U/kg/h and 0.5 U/kg/h) or ANF (0.5µg/kg/h) and CCK (10pmol/kg/h). The lowest dose to elicit secretory response was used for each peptide. Electrolyte composition and total protein concentration were measured and expressed as mEq or µg/min /100g body weight, respectively.
Role of the parasympathetic and sympathetic nervous system: We assessed the role of the parasympathetic nervous system in ANF response by atropine administration and truncal vagotomy. In a set of animals atropine was administered in bolus (75µg/kg) 30 min before the infusion of saline or ANF (1µg/kg/h), and by infusion (75µg/kg/h) during ANF or saline administration (34) . Subdiaphragmatic bilateral vagotomy was performed in another group of animals 2 h prior to the beginning of secretion experiments (ANF or saline infusion) by sectioning the vagal branches and vagal efferents at the level of the lower esophagus. Cervical vagotomy was not performed to prevent hemodynamic alterations resulting from the section of cardiac branches. Pancreatic juice samples were collected as indicated above. In each sample protein content was also assessed as previously indicated and expressed as µg/min/100 g body weight.
The participation of the sympathetic nervous system in ANF-evoked pancreatic secretion was assessed by combined administration of α-and β-adrenergic antagonists (32) .
A bolus of 0.5mg/kg phentolamine (α-adrenergic antagonist) and a bolus of 0.5mg/kg propranolol (β-adrenergic antagonist) were given intravenously 30 min before ANF 8 administration (27) . The α-adrenergic antagonist was also infused with ANF (1µg/kg/h) at a constant rate of 0.2 ml/kg/h.
Role of NO:
We sought to establish the participation of NO in ANF-stimulated pancreatic secretion. Rats were pre-treated with 5, 10 or 20mg/kg N ω Nitro-L arginine methyl ester (L-NAME) (NO synthase inhibitor) 15 min before pancreatic secretion experiments.
Pancreatic juice samples were collected as indicated above. Proteins were measured as previously indicated and expressed as µg/min/100 g body weight.
Role of NPR-C receptors: In order to investigate the possible participation of NPR-C receptors in ANF pancreatic response, animals were infused with the selective NPR-C agonist cANP (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) which is a truncated peptide that selectively binds to NPR-C receptors. The specific ligand of NPR-C was infused at doses of 1, 10 and 20µg/kg/hand pancreatic juice samples were collected, and proteins measured as described above.
Studies in isolated pancreatic acini. Phosphoinositide turnover was determined according
to Berridge et al., (3) . Briefly, isolated pancreatic acini (46) triphosphate, the immediate product of PLC activity, is the precursor from which the other forms are synthesized (41) . Results are expressed as percentage of control ± S.E.M.
We also studied the effect of ANF on cAMP accumulation. Isolated pancreatic acini 
Analysis of data:
All values are expressed as means ± SEM. ANOVA and the "t"test modified by Bonferroni were used for statistical analysis. A p of 0.05 or less was considered statistically significant.
Results
The present study was performed in anaesthetized rats that render similar protein output but lower basal pancreatic secretion than conscious rats (37) . The volume of pancreatic secretion in control animals was similar to those seen in other studies with anesthetized rats.
Effect of ANF on basal and hormone-evoked pancreatic secretion: All animals had similar basal pancreatic flow before any treatment (Data not shown). ANF (0.5, 1 and 2µg/kg/h) dose-dependently increased basal exocrine pancreatic secretion in the rat. (Fig.   1a ). Secretin and CCK also increased pancreatic flow in a dose-dependent fashion consistent with the role of these hormones in the regulation of pancreatic secretion (Fig 1b   and 1c) . The increase in pancreatic flow induced by the highest dose of ANF (2µg/kg/h) was lower than the effect achieved by the highest dose of secretin or CCK used.
ANF interacted with secretin and CCK, which are the major hormones that regulate pancreatic secretion. The co-infusion of 0.5U/kg/h secretin and 0.5µg/kg/h ANF showed that ANF potentiated secretin effect on pancreatic flow (Fig.2a) . Further, ANF also enhanced pancreatic flow in the presence of 0.05U/kg/h secretin which is considered to be a physiological dose. When 0.5µg/kg/h ANF was infused together with 10pmol/kg/h CCK, pancreatic flow was also increased. In this case, ANF did not potentiate CCK effect but both peptides showed an additive effect on pancreatic flow (Fig. 2b) .
Effect of ANF on the electrolytes and proteins of the pancreatic juice: ANF did not alter the concentration of sodium or potassium in the pancreatic juice (Data not shown). The concentration of these electrolytes remained unchanged with modifications of the pancreatic flow. ANF dose-dependently diminished the concentration of chloride and increased pH in the pancreatic juice ( Fig. 3a and 3b) , suggesting a stimulatory effect of ANF on pancreatic ductular secretion in the rat. ANF effect was more pronounced in the 12 presence of 0.5U/kg/h secretin. The infusion of ANF also increased protein concentration in a dose dependent manner (Fig. 4a) . The co-infusion of 0.5µg/kg/h ANF and 10pmol/kg/h CCK further increased protein concentration in the pancreatic juice (Fig. 4b) . Both peptides showed an additive effect on protein output. Secretin did not modify pancreatic protein output. The co-infusion of secretin and ANF enhanced protein secretion as observed with ANF alone (Fig. 4b) .
Role of the parasympathetic and sympathetic nervous system: Neither truncal vagotomy nor the administration of atropine abolished ANF response on pancreatic flow (Fig 5a and   5b ). Animals with truncal vagotomy or receiving atropine alone showed reduced pancreatic flow as compared with control rats supporting the physiological role of the vagus in the maintenance of basal pancreatic secretion. Pancreatic flow in these rats was reduced by approximately 40%. When 1µg/kg/h ANF was infused to rats with vagotomy or atropine treatment pancreatic flow was increased compared to control rats, but it was lower than the flow elicited by ANF alone. Pancreatic protein secretion was reduced in vagotomized and atropine-treated rats, but it was increased in the presence of ANF. ANF-evoked protein secretion was effected neither by vagotomy nor by atropine treatment (Fig. 8b) . These results suggest that ANF response is independent of the parasympathetic pathway.
The role of the sympathetic nervous system in ANF evoked pancreatic secretion was investigated by combined administration of α and β-adrenergic antagonists. The administration of phentolamine and propranolol did not alter either basal or ANF-evoked pancreatic flow. (Fig 6a) .
Role of NO and the hormones secretin and CCK:
The administration of a NO synthase inhibitor did not modify the stimulatory effect of ANF on exocrine pancreatic secretion.
Pretreatment with 5 or 10 or 20mg/kg L-NAME altered neither basal nor ANF-evoked pancreatic flow (Fig.6b) . Only results with 10mg/kg are shown. The administration of L-13 NAME decreased basal protein output but it did not modify ANF-evoked pancreatic protein secretion (Fig 8b) .
Role of NPR-C receptors:
The infusion of cANP (4-23 amide), that selectively binds to the NPR-C receptor, increased exocrine pancreatic secretion in a dose dependent fashion. This selective NPR-C receptor agonist mimicked ANF response in the pancreas supporting that ANF may enhance pancreatic secretion by NPR-C receptor stimulation (Fig.7) . The co administration of ANF and cANP (4-23 amide) did not further increase pancreatic flow.
Protein output was also increased by (4-23 amide) infusion (Fig.8a) . Equimolar concentrations of ANF and cANP (4-23 amide) evoked similar pancreatic protein output.
Effect of ANF on PI hydrolysis and cAMP content in isolated pancreatic acini: One, 10, and 100nM ANF enhanced PI hydrolysis in isolated pancreatic acini in a dose dependent manner. The stimulation of PI hydrolysis evoked by 1, 10 and 100nM ANF was prevented by 10µM U73122 (PLC inhibitor) (Fig. 9) , supporting selective activation of PLC.
ANF did not modify basal cAMP content in isolated pancreatic acini suggesting non-coupling of the NPR-C receptor to AC inhibition in the exocrine pancreas (Table I) .
As ANF may exert its effects in stimulated systems, we investigated the effect of this peptide on FSK-evoked cAMP formation. The increase in cAMP content induced by FSK was not prevented by 100nM ANF.
Effect of ANF on MAP:
The lowest dose of ANF (0.5 µg/kg/h) did not modify MAP whereas doses of 1 and 2 µg/kg/h ANF decreased it within the first 3 min. Blood pressure was normalized within 5 min and remained unchanged for the rest of the experiment (30 min) (Table II) . Previous investigations showed that ANF affects neither total pancreatic blood flow nor other local flows such as duodenal, colonic or hepatic (10) . These data support that ANF pancreatic response is not mediated by hemodynamic changes and suggest that factors other than vascular may mediate ANF stimulatory effect in the exocrine pancreas.
ANF increased protein concentration in the pancreatic juice. ANF-evoked protein increase was lower than the increase stimulated by any dose of CCK. Further, ANF-evoked protein secretion was affected neither by vagotomy nor by atropine or L-NAME pretreatment. When ANF was co-infused with CCK, protein concentration was further increased. In previous investigations we reported that in the parotid gland ANF enhances β-adrenergic-evoked protein output. The effect is not abolished by a β-adrenergic antagonist and involves the participation of the PI pathway, that is the intracellular signaling that stimulates the stimulus-secretion coupling mechanism in salivary glands (5, 6) . In the pancreatic acinar cells CCK stimulates PLC and promotes intracellular calcium increase leading to amylase output (29) . In view that ANF stimulated basal as well as CCK-evoked protein output in the exocrine pancreas we investigated whether this peptide stimulated PI hydrolysis. Results showed that ANF enhanced PI hydrolysis in a dose dependent manner.
The stimulation of the PI pathway induced by ANF was prevented by U73122 (a specific PLC inhibitor) supporting that ANF stimulates PLC in the exocrine pancreas. Our findings suggest that PI hydrolysis is the intracellular signaling pathway that mediates the stimulatory effect of ANF in the exocrine pancreas. 16 The majority of ANF biological actions are mediated by GC coupled receptors (2).
NPR-A and NPR-B are coupled to GC and promote cGMP formation upon stimulation whereas NPR-C functions as a clearance receptor but it is also coupled to the inhibition of adenylyl cyclase and/or the stimulation of PLC (2). In the exocrine pancreas the stimulus secretion coupling mechanism involves the participation of cAMP and the PI signal transduction pathways in which calcium is used as a second messenger (29) . Present results
showed that ANF stimulated PLC activity in the exocrine pancreas supporting a direct effect on the stimulus-secretion coupling mechanism likely mediated by NPR-C activation. suggesting that ANF response is independent of the parasympathetic pathway. Further, these findings support that the stimulatory effect of the parasympathetic nervous system on pancreatic secretion appears to be additive to that of ANF. In addition, the finding that ANF-evoked protein secretion was not affected by vagotomy or atropine treatment further supports that ANF response is not mediated by the parasympathetic system.
We also investigated the role of the adrenergic nervous system in ANF response.
Previous investigations carried out in our laboratory showed that ANF inhibits norepinephrine metabolism in the central nervous system and adrenal medulla of the rat 18 (47-49). However, combined administration of α and β adrenergic antagonists, did not affect basal or ANF-stimulated pancreatic flow suggesting that the inhibition of the adrenergic activity does not participate in ANF response.
Present results suggest that ANF is likely to have a direct effect on acinar cells through the activation of cell surface receptors or an indirect effect through the release of intrapancreatic neurotransmitters like NO. Both ANF and NO promote cGMP generation but through the activation of distinct GCs. ANF stimulates particulate GC whereas NO activates soluble GC. Cyclic GMP generation induced by ANF and NO has been reported in the pancreas (19, 25) . We investigated whether NO mediated ANF stimulatory effect on pancreatic secretion based upon the finding that the pretreatment with a NO synthase inhibitor suppresses the exocrine pancreatic response to a variety of secretory stimulants (8, 25) . Pretreatment with L-NAME did not inhibit basal or ANF-evoked pancreatic fluid and protein secretion at the doses used, suggesting that NO is not involved in ANF response.
The observation that ANF increased pancreatic fluid and protein output suggested that ANF response could be partly mediated by secretin and/or CCK release. Pituitary adenylyl cyclase-activating peptide (PACAP) increases pancreatic flow through the release of these hormones (27) . However these hormones appear not to be released by ANF. CCK at physiological doses acts through stimulation of vagal afferent pathways to induce pancreatic enzyme secretion (28) . When ANF was infused to vagotomized or atropinetreated rats it increased protein output to the same extent as in control rats, suggesting that CCK is not involved in the biologic response of ANF. Further, secretin and CCK evoked pancreatic secretion is partly mediated by NO (24) . However pretreatment with L-NAME affected neither pancreatic fluid nor protein output evoked by ANF suggesting that CCK and secretin are not involved in ANF response. Our results permit us to conclude that ANF stimulates exocrine pancreatic secretion through NPR-C activation coupled to the PI pathway but not to AC inhibition. 
